Water Ingestion as Prophylaxis Against Syncope

  • Chih-Cherng Lu
    From the Autonomic Dysfunction Center (C.C.L., A.D., S.Y.P., D.R.), Division of Pharmacology (D.R.), General Clinical Research Center (P.A.H., D.W.B., D.R.), and Division of General Internal Medicine, Department of Medicine (D.W.B.), Vanderbilt University School of Medicine, Nashville, Tenn; the National Defense Medical Center, Taipei, Taiwan, ROC (C.C.L., C.S.T.); and Franz-Volhard Clinical Research Center, Medical Faculty of the Charite, Humboldt-University, Berlin, Germany (J.J.).
  • André Diedrich
    From the Autonomic Dysfunction Center (C.C.L., A.D., S.Y.P., D.R.), Division of Pharmacology (D.R.), General Clinical Research Center (P.A.H., D.W.B., D.R.), and Division of General Internal Medicine, Department of Medicine (D.W.B.), Vanderbilt University School of Medicine, Nashville, Tenn; the National Defense Medical Center, Taipei, Taiwan, ROC (C.C.L., C.S.T.); and Franz-Volhard Clinical Research Center, Medical Faculty of the Charite, Humboldt-University, Berlin, Germany (J.J.).
  • Che-Se Tung
    From the Autonomic Dysfunction Center (C.C.L., A.D., S.Y.P., D.R.), Division of Pharmacology (D.R.), General Clinical Research Center (P.A.H., D.W.B., D.R.), and Division of General Internal Medicine, Department of Medicine (D.W.B.), Vanderbilt University School of Medicine, Nashville, Tenn; the National Defense Medical Center, Taipei, Taiwan, ROC (C.C.L., C.S.T.); and Franz-Volhard Clinical Research Center, Medical Faculty of the Charite, Humboldt-University, Berlin, Germany (J.J.).
  • Sachin Y. Paranjape
    From the Autonomic Dysfunction Center (C.C.L., A.D., S.Y.P., D.R.), Division of Pharmacology (D.R.), General Clinical Research Center (P.A.H., D.W.B., D.R.), and Division of General Internal Medicine, Department of Medicine (D.W.B.), Vanderbilt University School of Medicine, Nashville, Tenn; the National Defense Medical Center, Taipei, Taiwan, ROC (C.C.L., C.S.T.); and Franz-Volhard Clinical Research Center, Medical Faculty of the Charite, Humboldt-University, Berlin, Germany (J.J.).
  • Paul A. Harris
    From the Autonomic Dysfunction Center (C.C.L., A.D., S.Y.P., D.R.), Division of Pharmacology (D.R.), General Clinical Research Center (P.A.H., D.W.B., D.R.), and Division of General Internal Medicine, Department of Medicine (D.W.B.), Vanderbilt University School of Medicine, Nashville, Tenn; the National Defense Medical Center, Taipei, Taiwan, ROC (C.C.L., C.S.T.); and Franz-Volhard Clinical Research Center, Medical Faculty of the Charite, Humboldt-University, Berlin, Germany (J.J.).
  • Daniel W. Byrne
    From the Autonomic Dysfunction Center (C.C.L., A.D., S.Y.P., D.R.), Division of Pharmacology (D.R.), General Clinical Research Center (P.A.H., D.W.B., D.R.), and Division of General Internal Medicine, Department of Medicine (D.W.B.), Vanderbilt University School of Medicine, Nashville, Tenn; the National Defense Medical Center, Taipei, Taiwan, ROC (C.C.L., C.S.T.); and Franz-Volhard Clinical Research Center, Medical Faculty of the Charite, Humboldt-University, Berlin, Germany (J.J.).
  • Jens Jordan
    From the Autonomic Dysfunction Center (C.C.L., A.D., S.Y.P., D.R.), Division of Pharmacology (D.R.), General Clinical Research Center (P.A.H., D.W.B., D.R.), and Division of General Internal Medicine, Department of Medicine (D.W.B.), Vanderbilt University School of Medicine, Nashville, Tenn; the National Defense Medical Center, Taipei, Taiwan, ROC (C.C.L., C.S.T.); and Franz-Volhard Clinical Research Center, Medical Faculty of the Charite, Humboldt-University, Berlin, Germany (J.J.).
  • David Robertson
    From the Autonomic Dysfunction Center (C.C.L., A.D., S.Y.P., D.R.), Division of Pharmacology (D.R.), General Clinical Research Center (P.A.H., D.W.B., D.R.), and Division of General Internal Medicine, Department of Medicine (D.W.B.), Vanderbilt University School of Medicine, Nashville, Tenn; the National Defense Medical Center, Taipei, Taiwan, ROC (C.C.L., C.S.T.); and Franz-Volhard Clinical Research Center, Medical Faculty of the Charite, Humboldt-University, Berlin, Germany (J.J.).

抄録

<jats:p> <jats:bold> <jats:italic>Background—</jats:italic> </jats:bold> Water ingestion raises blood pressure substantially in patients with perturbed autonomic control and more modestly in older subjects. It is unclear whether prophylactic water drinking improves orthostatic tolerance in normal healthy adults. </jats:p> <jats:p> <jats:bold> <jats:italic>Methods and Results—</jats:italic> </jats:bold> Twenty-two healthy subjects, 18 to 42 years of age, with no history of syncope underwent head-up tilt-table testing at 60° for 45 minutes or until presyncope or syncope occurred. In their initial test, participants were randomized to either 16 oz (473 mL) of water drinking 5 minutes before tilt-table testing or tilt-table testing alone, with the alternative in a second test on a different day. During the first 30 minutes of tilt, 8 of 22 subjects without water experienced presyncope but only 1 of 22 who had ingested water ( <jats:italic>P</jats:italic> =0.016). Water drinking attenuated the heart rate increase associated with tilt ( <jats:italic>P</jats:italic> <0.001) while accentuating the increase in total peripheral resistance ( <jats:italic>P</jats:italic> =0.012). The average time study participants tolerated head-up tilt was 26% longer after water (41.1±8.1 versus 32.6±14.3 minutes, mean±SD), with a pairwise mean difference of 8.5±14.0 minutes (95% CI, 2.3 to 14.7 minutes; <jats:italic>P</jats:italic> =0.011). </jats:p> <jats:p> <jats:bold> <jats:italic>Conclusions—</jats:italic> </jats:bold> Water enhances tolerance of upright posture. The effect of water is mediated by increased peripheral vascular resistance. Water ingestion may constitute a simple and effective prophylaxis against vasovagal reactions in healthy subjects, such as those associated with blood donation. </jats:p>

収録刊行物

  • Circulation

    Circulation 108 (21), 2660-2665, 2003-11-25

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ